Page last updated: 2024-08-16

technetium tc 99m sestamibi and Adverse Drug Event

technetium tc 99m sestamibi has been researched along with Adverse Drug Event in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Israel, O; Kapeliovich, M; Keidar, Z; Koskosi, A; Marai, I; Massalha, S; Reizberg, I; Sholy, H	1

Other Studies

1 other study(ies) available for technetium tc 99m sestamibi and Adverse Drug Event

Article	Year
Conduction abnormalities during dipyridamole stress testing. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:2 Topics: Atrioventricular Block; Bradycardia; Causality; Comorbidity; Coronary Artery Disease; Dipyridamole; Drug-Related Side Effects and Adverse Reactions; Exercise Test; Female; Humans; Incidence; Israel; Male; Radiopharmaceuticals; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents	2017

Article

Year

Conduction abnormalities during dipyridamole stress testing.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:2

Topics: Atrioventricular Block; Bradycardia; Causality; Comorbidity; Coronary Artery Disease; Dipyridamole; Drug-Related Side Effects and Adverse Reactions; Exercise Test; Female; Humans; Incidence; Israel; Male; Radiopharmaceuticals; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2017